A study of 105 NSCLC samples showed that YB-1 and EGFR were significantly co-expressed and knockdown of YB-1 in two NSCLC cell lines resulted in reduction of EGFR (Hyogotani et al., 2012). Here, YBX1 is linked to non-small cell lung carcinoma.